UBS: AIA's Worst-Case Scenario Already Priced; Maintain Buy

Overview

UBS released research on AIA, maintaining a Buy rating and HK$104 target price. The core thesis is that despite uncertainties surrounding the impact of Regulation No. 837 on the Mainland Visitor (MCV) insurance business, the current share price has largely priced in the 'worst-case scenario' of future MCV new business dropping to zero—a highly unlikely event. As long as the regulatory outcome does not result in a comprehensive ban on new MCV business, there is room for share price appreciation. Meanwhile, fundamentals outside of MCV remain solid, and the current approx. 1x PEV valuation provides an attractive risk-reward ratio.

Core views

Regulatory Expectation Gap and Sentiment Recovery: The report points out that market concerns regarding MCV business are overblown. Three arguments suggest the worst-case scenario is already priced in: First, channel surveys indicate daily operations such as sales and premium payments remain stable; the recent restrictions by the HKMA on bank accounts primarily target securities trading rather than insurance. Second, MCV business still has a compliance basis under the regulatory frameworks in both Mainland China and Hong Kong. Third, the Financial Secretary of the HKSAR expressed support from the Central Government for Hong Kong's role as an international financial hub and its intention to optimize cross-border wealth management connectivity during an event on June 10. Against this backdrop, combined with intensive promotional activities since mid-May, AIA Hong Kong's Q2 New Business Value (NBV) is expected to exceed expectations. Regional Fundamentals and Growth Resilience: Despite regulatory disruption to a single business line, AIA's overall fundamentals remain intact. In China, leveraging its high-end agent force penetrating middle-class and affluent segments, NBV CAGR is projected at 18% from 2025-2030. For newly entered markets (post-2019), the target NBV CAGR for the same period is 40%, while existing markets still have double-digit growth room given penetration rates in the single digits. In Southeast Asia, Thailand's annualized new premiums grew 14% YoY in April, a significant improvement from the Q1 decline, validating the company's ability to withstand macro volatility; Singapore's Q2 NBV growth is expected to accelerate on a low base, and Malaysia's agent channel continues to recover. Valuation Margin of Safety: Current share price corresponds to a 1.04x PEV, with a forward operating Return on Embedded Value (RoEV) of 16%, implying a new business multiple of less than 1x. This level barely incorporates any growth expectations and is 1.1 standard deviations below the 5-year average, providing a high margin of safety for medium-to-long-term allocation.

Analysis framework

The report adopts an analysis approach combining 'Extreme Scenario Pricing Test' with 'Segment Fundamental Verification'. First, by setting the extreme pessimistic assumption that 'MCV new business drops to zero', it compares the current share price position to determine if downside risks are sufficiently released. Subsequently, it segregates the MCV business from the company as a whole to independently examine the endogenous growth momentum and channel data in core markets like China and Southeast Asia, confirming that the core foundation remains uneroded. Finally, it uses insurance-specific valuation metrics such as PEV and new business multiples to quantify the discount of the current price relative to embedded value and future growth potential, concluding that the risk-reward is attractive.

Methodology notes

• Industry-Specific Metrics (Insurance)Embedded Value (EV) / New Business Value (NBV)

  P/EV and New Business Multiple

  Insurers commonly use P/EV (Price per Share / Embedded Value per Share) to measure the value of legacy business and use the new business multiple to measure the premium for incremental business. When P/EV approaches 1x and the new business multiple is <1, it typically means the market only values legacy assets without granting a premium for future new sales, often signaling a valuation bottom.

• Event Trading and Behavioral FinanceExpectation Gap / Expectation Management

  Worst-Case Scenario Pricing Test

  When regulatory or policy uncertainty is high, analysts construct an extremely pessimistic hypothetical scenario (e.g., a specific business line stagnates completely) and assess whether the current share price reflects this scenario. If the share price decline has matched or even exceeded the loss from this extreme scenario, it suggests that negative news is fully priced in; subsequent marginal changes better than expected could trigger valuation repair.

• Industry/Industrial Analysis FrameworkPenetration S-curve

  Low Penetration Driving Long-Term Growth

  The report notes that AIA's target customer penetration in existing markets is currently in the single digits, placing it at the early stage of the S-curve. In the low-penetration interval, even with external environmental fluctuations, the industry and the company can achieve structural growth exceeding GDP by increasing coverage rates. This is one of the core logics supporting its medium-to-long-term NBV growth forecast.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• AIA Group Limited (1299.HK)

  Core Beneficiary: Worst-case scenario already priced, solid fundamentals, and valuation at historical lows

  Strengths

  Deep moat in high-end agents; diversified geographic footprint mitigating single-market risk; high return on embedded value; cross-border business compliance foundation remains

  Weaknesses

  Short-term MCV business suppressed by regulatory sentiment; certain Southeast Asian markets affected by macro volatility

  Comparison

  Compared to peers, AIA holds distinct advantages in affluent customer penetration and geographical diversification, with a larger valuation discount

  Risks

  Complete ban on MCV business; adverse movements in exchange rates and interest rates; severe capital market volatility; deterioration in mortality/morbidity/investment return/expense experience

Key data

• Target PriceHK$104.00Maintain Buy rating; derived based on SOTP valuation method
• Current P/EV1.04xImplied new business multiple <1x; 1.1 standard deviations below 5-year average
• Forward Operating RoEV16%12-month rolling operating return on embedded value
• China Region VNB CAGR (2025-30E)18%Benefiting from high-end agent strategy and middle-class penetration
• New Market VNB CAGR (2025-30E)40%Growth targets for regions entered after 2019
• Thailand ANP YoY Growth (April 2026)+14%Significant recovery from -2% in Q1, reflecting counter-cyclical resilience
• Forecasted Share Price Appreciation41.0%Upside space calculated based on target price and current price

Impact & implications

For AIA, the current share price level implies limited downside risk and prominent option value for upside. Should subsequent regulatory details be implemented without a comprehensive ban, or if Q2 performance validates MCV business resilience, these could trigger a valuation reversion to the mean. For the Pan-Asia insurance sector, as AIA is an industry benchmark, stabilization of its valuation also helps alleviate excessive market concerns regarding regional regulatory risks.

Risks

• Adverse foreign exchange and interest rate trends
• Significant capital market volatility
• Worse-than-expected mortality, morbidity, investment return, and expense experience
• More stringent regulatory outcome for Mainland visitor business than expected (e.g., comprehensive ban)

What to watch

• Final detailed implementation rules of Regulation No. 837 concerning Mainland visitor insurance business
• AIA's Q2 2026 New Business Value performance
• Further guidelines from HKMA and IA regarding cross-border insurance sales
• Trends in monthly premium data for Southeast Asian markets such as Thailand and Singapore